Status:
UNKNOWN
Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension
Lead Sponsor:
Hossam Ahmed Abd Ellah
Collaborating Sponsors:
Assiut University
Conditions:
Postpartum Preeclampsia
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal de...
Detailed Description
Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal de...
Eligibility Criteria
Inclusion
- Women who have hypertension during pregnancy and persist after delivery till discharge of hospital about 2 days of monitoring the blood pressure
Exclusion
- Women with history of secondary hypertension Women with eclampsia who need intensive care unit admission and indicated other drugs rather than oral nifedipine and oral labetalol Women who have any contraindication to Nifedipine or labetalol
Key Trial Info
Start Date :
January 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03449277
Start Date
January 19 2018
End Date
March 1 2019
Last Update
April 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hossam Ahmed Abd Ellah
Asyut, Egypt